The CSL share price is at a 6-year low. Should you buy?
Image source: Getty Images
The CSL Ltd (ASX: CSL) share price is trading at a six-year low, closing at $215.16 on Tuesday, down 0.57% for the day.
The market’s largest ASX 200 healthcare share has lost a fifth of its market cap since the company released its FY25 report last Tuesday.
Let’s recap why.
CSL share price falls to a 6-year low
CSL surprised the market by announcing the demerger of Seqirus and a multi-year share buyback targeting US$500 million in FY26.
Seqirus is CSL’s vaccines division, and the company intends to list it separately on the ASX in FY26.
CSL also confirmed a restructure ahead, stating that growth had led to operational complexity that now requires streamlining.
This…
